A 72-year-old man was referred to our hospital for treatment for
rectal cancer. Digital rectal examination and colonoscopy revealed a 4 cm
tumor located at the anterior rectal wall 5 cm away from the anal verge, and pathological examination confirmed that the
tumor was
adenocarcinoma. A computed tomography scan detected neither regional
lymph node metastasis nor distant
metastasis. Hence, he was diagnosed with cT3N0M0, cStage Ⅱa
rectal cancer. The preoperative general examination revealed
bradyarrhythmia and severe
emphysema, and he was considered to be high risk for
general anesthesia. After placement of a pacemaker, preoperative
capecitabine-based
chemoradiotherapy(CRT)(50.4 Gy in 28 fractions of 1.8 Gy each)was implemented. The digital rectal examination and imaging evaluation 4 weeks after preoperative CRT revealed that the
tumor disappeared, and pathological examination showed no malignant findings. Considering the risks of
general anesthesia, the"watch and wait
therapy"approach was adopted with sufficient informed consent. At present, 15 months after preoperative CRT, no evidence of regrowth or distant
metastasis has been detected under rigorous follow- up evaluations.